Qin Ma
Research Subjects
Research Interests
Qin Ma has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
Adam Santaniello
1 shared publication- Alessandro Didonna
Department of Anatomy and Cell Biology, Brody School of Medicine, East Carolina University, Greenville, USA
1 shared publication Ari J. Green
1 shared publicationBruce A. C. Cree
Weill Institute for Neurosciences, Department of Neurology, University of California, San Francisco, CA 94158
1 shared publicationChu-Yueh Guo
1 shared publicationEduardo Caverzasi
1 shared publication
Latest Publications
- Open Access
- 15 December 2021
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 118 (51)
Specific hypomethylation programs underpin B cell activation in early multiple sclerosis
Significance: Cellular and molecular mediators driving multiple sclerosis (MS) pathology have been discovered to a great extent. However, the early molecular events leading to aberrant immune responses remain largely unknown. In this study, we combined bisulfite sequencing with transcriptome profiling to characterize the epigenetic landscape of four peripheral immune cell populations isolated from newly diagnosed, untreated MS patients and healthy individuals. We demonstrate widespread hypomethylation in CD19 + B cells at clinical disease onset. Notably, this epigenetic signature is functionally linked with the overactivation of B cells. Altogether, our results pinpoint the role of aberrant DNA methylation in connecting defects in the periphery with central nervous system autoimmunity and corroborate the key role of B cells in the initial stages of MS.
- 15 December 2021
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 118 (51)
Open AccessSpecific hypomethylation programs underpin B cell activation in early multiple sclerosis
Significance: Cellular and molecular mediators driving multiple sclerosis (MS) pathology have been discovered to a great extent. However, the early molecular events leading to aberrant immune responses remain largely unknown. In this study, we combined bisulfite sequencing with transcriptome profiling to characterize the epigenetic landscape of four peripheral immune cell populations isolated from newly diagnosed, untreated MS patients and healthy individuals. We demonstrate widespread hypomethylation in CD19 + B cells at clinical disease onset. Notably, this epigenetic signature is functionally linked with the overactivation of B cells. Altogether, our results pinpoint the role of aberrant DNA methylation in connecting defects in the periphery with central nervous system autoimmunity and corroborate the key role of B cells in the initial stages of MS.